Generation of cytotoxic antibodies to the B16 murine melanoma using a formalinized vaccine

作者: David Shrayer , Nicolas Kouttab , Abby Maizel , Harold Wanebo , Vincent J. Hearing

DOI: 10.1002/IJC.2910530428

关键词: In vitroActive immunizationHumoral immunityAntibodyAntigenBiologyMelanoma VaccineCytotoxicityVirologyCytotoxic T cellImmunology

摘要: The goal of our experiments was to determine the extent which humoral response a melanoma vaccine elicits production cytotoxic antibodies in tumor-challenged mice. Mice were immunized with produced from formalinized extracellular antigens (FECA) derived B16 F10 melanomas. that recognized preparation determined by ELISA, as their cross-reactivity B700 antigen. shown be anti-proliferative inhibition tritiated thymidine incorporation into DNA cultured target cells and assays for complement-mediated antibody-dependent cellular cytotoxicity. Flow cytometric analyses indicated approximately 60% specifically bound antibody immune sera. These results confirm is significant antigenic component FECA vaccine, provide encouragement this approach developing useful vaccines.

参考文章(24)
R Versteeg, L T Peltenburg, A C Plomp, P I Schrier, High expression of the c-myc oncogene renders melanoma cells prone to lysis by natural killer cells. Journal of Immunology. ,vol. 143, pp. 4331- 4337 ,(1989)
T Shiohara, K Jacobson, N H Ruddle, G Moellmann, A B Lerner, E Kuklinska, Anti-tumor activity of class II MHC antigen-restricted cloned autoreactive T cells. II. Novel immunotherapy of B16 melanomas by local and systemic adoptive transfer. Journal of Immunology. ,vol. 138, pp. 1979- 1986 ,(1987)
Vincent J. Hearing, John J. Marchalonis, Douglas M. Gersten, Studies on the Relationship of the B700 and B50 Murine Melanoma Antigens JNCI: Journal of the National Cancer Institute. ,vol. 77, pp. 763- 766 ,(1986) , 10.1093/JNCI/77.3.763
Douglas M. Gersten, Vincent J. Hearing, Antigens of murine melanoma and their cross-species reactivity. Pathobiology. ,vol. 60, pp. 49- 56 ,(1992) , 10.1159/000163697
D. M. Gersten, V. J. Hearing, J. J. Marchalonis, Characterization of immunologically significant unique B16 melanoma proteins produced in vivo and in vitro Proceedings of the National Academy of Sciences of the United States of America. ,vol. 78, pp. 5109- 5112 ,(1981) , 10.1073/PNAS.78.8.5109
DOUGLAS M. GERSTEN, VINCENT J. HEARING, Demonstration of B700 cross-reactive antigens on human and other animal melanomas. Pigment Cell Research. ,vol. 1, pp. 434- 438 ,(1988) , 10.1111/J.1600-0749.1988.TB00147.X
Douglas M. Gersten, Laura J. Williams, Dana Moody, Paul M. Montague, Lloyd W. Law, Vincent J. Hearing, The intracellular association of B700 and B50 murine melanoma antigens and their role in tumor rejection. International Journal of Cancer. ,vol. 43, pp. 497- 500 ,(1989) , 10.1002/IJC.2910430326
Yasushi Tomita, Paul M. Montague, Vincent J. Hearing, Monoclonal antibody production to a B16 melanoma associated antigen International Journal of Cancer. ,vol. 35, pp. 543- 547 ,(1985) , 10.1002/IJC.2910350419